» Articles » PMID: 33605492

Heterogeneous Long-term Trajectories of Glycaemic Control in Type 1 Diabetes

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2021 Feb 19
PMID 33605492
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: We aimed to identify long-term HbA1c trajectories and examine associated characteristics in an observational, childhood-onset (<17 years) type 1 diabetes cohort.

Methods: Data are from the Epidemiology of Diabetes Complications study, comprising 405 participants with ≥2 of seven possible HbA1c measurements over follow-up (1988-2013) and available DNA (baseline mean diabetes duration 21 years, 53% men). HbA1c trajectories were estimated using latent class growth models. Baseline and change in participant characteristics were compared across trajectories.

Results: Five HbA1c trajectories were identified: low (51%), intermediate stable (22%), improved (19%), high stable (6%), and worsened (2%; not included in analyses). Age, diabetes duration, diabetes onset age, and sex did not differ across trajectories. Characteristics did not differ significantly between intermediate stable and low trajectories at baseline, though albumin excretion rate (AER, p = 0.0002) and estimated glomerular filtration rate (eGFR, p = 0.001) worsened slightly more in intermediate stable over time. Improved and high stable trajectories had higher baseline LDL-c (p = 0.002 and 0.003, respectively). Improved trajectory increased median self-monitoring of blood glucose from <1 to 3.5 times/day (p < 0.0001) and had larger LDL-c improvement (p = 0.004) but greater worsening of AER (p < 0.0001) and eGFR (p < 0.0001) than low. The A allele of rs12970134 (near MC4R) was associated with improved (p = 0.0003) or high stable (p = 0.001) HbA1c trajectory, both patterns with high baseline HbA1c.

Conclusions: Long-term HbA1c trajectories were primarily associated with modifiable factors in this type 1 diabetes cohort. The intermediate stable pattern had a risk factor profile that suggests some protection against adverse metabolic effects of chronic hyperglycaemia, warranting further study.

Citing Articles

DNA methylation and 28-year cardiovascular disease risk in type 1 diabetes: the Epidemiology of Diabetes Complications (EDC) cohort study.

Miller R, Mychaleckyj J, Onengut-Gumuscu S, Feingold E, Orchard T, Costacou T Clin Epigenetics. 2023; 15(1):122.

PMID: 37533055 PMC: 10394855. DOI: 10.1186/s13148-023-01539-0.


DNA methylation is associated with glycemic control over 28 years in type 1 diabetes: findings from the Pittsburgh Epidemiology of Diabetes Complications (EDC) study.

Miller R, Mychaleckyj J, Onengut-Gumuscu S, Orchard T, Costacou T BMJ Open Diabetes Res Care. 2023; 11(1).

PMID: 36604111 PMC: 9827189. DOI: 10.1136/bmjdrc-2022-003068.


Joint 30-year HbA1c and lipid trajectories and mortality in type 1 diabetes.

Miller R, Orchard T, Costacou T Diabetes Res Clin Pract. 2022; 185:109787.

PMID: 35183647 PMC: 9018613. DOI: 10.1016/j.diabres.2022.109787.


30-Year Cardiovascular Disease in Type 1 Diabetes: Risk and Risk Factors Differ by Long-term Patterns of Glycemic Control.

Miller R, Orchard T, Costacou T Diabetes Care. 2021; 45(1):142-150.

PMID: 34782353 PMC: 8753768. DOI: 10.2337/dc21-1381.


Data-driven identification of temporal glucose patterns in a large cohort of nondiabetic patients with COVID-19 using time-series clustering.

Mistry S, Gouripeddi R, Facelli J JAMIA Open. 2021; 4(3):ooab063.

PMID: 34409266 PMC: 8364667. DOI: 10.1093/jamiaopen/ooab063.

References
1.
Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

2.
Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J . Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010; 59(12):3229-39. PMC: 2992787. DOI: 10.2337/db10-0502. View

3.
Miller R, Costacou T, Orchard T . Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and.... Diabetes. 2018; 68(2):409-419. PMC: 6341302. DOI: 10.2337/db18-0515. View

4.
Clements M, Schwandt A, Donaghue K, Miller K, Luck U, Couper J . Five heterogeneous HbA1c trajectories from childhood to adulthood in youth with type 1 diabetes from three different continents: A group-based modeling approach. Pediatr Diabetes. 2019; 20(7):920-931. DOI: 10.1111/pedi.12907. View

5.
Helgeson V, Snyder P, Seltman H, Escobar O, Becker D, Siminerio L . Brief report: trajectories of glycemic control over early to middle adolescence. J Pediatr Psychol. 2010; 35(10):1161-7. PMC: 2955830. DOI: 10.1093/jpepsy/jsq011. View